ANG Lifesciences India Live BSE/NSE | ANG Lifesciences India Fundamenta data | ANG Lifesciences India Balance sheet | ANG Lifesciences India Quarterly Results | ANG Lifesciences India Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

22.83
3.75
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

42.03
N/A
0.79

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

EBITDA CAGR (%)

10 Years
5 Years
3 Years

PAT CAGR (%)

10 Years
5 Years
3 Years

P:E (Median)

8 Years
5 Years
3 Years

P:BV (Average)

8 Years
5 Years
3 Years

EV:EBITDA (Average)

8 Years
5 Years
3 Years

Quarterly Results

Standalone Figures in Rs. Crores

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Description Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var% Sep 19 Sep 18 Var%
Net Sales 0 0 0 0 0 0 0 0 0 0 0 0
Expenses 0 0 0 0 0 0 0 0 0 0 0 0
EBITDA 0 0 0 0 0 0 0 0 0 0 0 0
EBIDTM 0% 0% 0% 0% 0% 0% 0% 0%
Other Income 0 0 0 0 0 0 0 0 0 0 0 0
Interest 0 0 0 0 0 0 0 0 0 0 0 0
Depreciation 0 0 0 0 0 0 0 0 0 0 0 0
PBT 0 0 0 0 0 0 0 0 0 0 0 0
Tax 0 0 0 0 0 0 0 0 0 0 0 0
PAT 0 0 0 0 0 0 0 0 0 0 0 0
PATM 0% 0% 0% 0% 0% 0% 0% 0%
EPS 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0 0.00 0.00 0

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Net Sales - 122 76 68 55 37 34 16 7 Net Sales Growth - 60% 12% 23% 49% 7% 112% 140% Cost Of Goods Sold - 88 53 48 41 27 26 11 5 Gross Profit - 34 23 20 14 10 9 5 2 GP Margin - 28% 30% 29% 26% 27% 26% 30% 27% Total Expenditure - 110 69 61 50 34 30 14 7 Power & Fuel Cost - 3 2 2 0 0 0 0 0 % Of Sales - 2% 2% 2% 0% 0% 0% 0% 0% Employee Cost - 6 6 4 3 2 1 1 0 % Of Sales - 5% 7% 6% 6% 6% 3% 4% 7% Manufacturing Exp. - 5 4 3 0 0 0 0 0 % Of Sales - 4% 5% 4% 0% 0% 0% 0% 0% General & Admin Exp. - 5 3 2 6 5 3 2 1 % Of Sales - 4% 4% 4% 11% 12% 8% 11% 16% Selling & Distn. Exp. - 2 1 2 0 0 0 0 0 % Of Sales - 1% 2% 2% 0% 0% 0% 0% 0% Miscellaneous Exp. - 2 0 1 0 0 0 0 0 % Of Sales - 1% 1% 1% 0% 0% 0% 0% 0% EBITDA - 12 8 7 5 3 5 3 0 EBITDA Margin - 10% 10% 10% 9% 8% 14% 16% 4% Other Income - 0 1 0 0 0 0 0 0 Interest - 3 2 2 2 2 2 2 2 Depreciation - 1 1 1 1 1 3 1 1 PBT - 8 5 4 2 1 0 0 -2 Tax - 2 1 1 1 0 0 0 0 Tax Rate - 30% 25% 26% 26% 33% 56% 140% 14% PAT - 6 4 3 2 0 0 0 -2 PAT before Minority Interest - 6 4 3 2 0 0 0 -2 Minority Interest - 0 0 0 0 0 0 0 0 PAT Margin - 5% 5% 4% 3% 1% 1% 0% -25% PAT Growth - 52% 32% 71% 312% 111% 417% 96% EPS - 10.87 7.15 5.42 3.17 0.77 0.37 -0.12 -3.29

Description

TTM

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Net Sales

122

Net Sales Growth

60%

12%

23%

49%

112%

140%

Cost Of Goods Sold

Gross Profit

GP Margin

28%

30%

29%

26%

27%

26%

30%

27%

Total Expenditure

110

Power & Fuel Cost

% Of Sales

Employee Cost

% Of Sales

Manufacturing Exp.

% Of Sales

General & Admin Exp.

% Of Sales

11%

12%

11%

16%

Selling & Distn. Exp.

% Of Sales

Miscellaneous Exp.

% Of Sales

EBITDA

EBITDA Margin

10%

14%

16%

Other Income

Interest

Depreciation

PBT

-2

Tax

Tax Rate

30%

25%

26%

33%

56%

140%

14%

PAT

-2

PAT before Minority Interest

-2

Minority Interest

PAT Margin

-25%

PAT Growth

52%

32%

71%

312%

111%

417%

96%

EPS

10.87

7.15

5.42

3.17

0.77

0.37

-0.12

-3.29

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Shareholder's Funds 29 23 7 5 3 3 2 2 Share Capital 5 5 4 4 4 4 4 4 Total Reserves 24 18 4 1 -1 -1 -1 -1 Non-Current Liabilities 10 10 5 7 8 10 11 2 Secured Loans 4 6 3 5 5 7 8 0 Unsecured Loans 2 2 2 2 3 3 3 3 Long Term Provisions 0 0 0 0 0 0 0 0 Current Liabilities 42 35 34 24 15 13 8 13 Trade Payables 22 22 21 15 10 9 5 2 Other Current Liabilities 6 6 5 3 3 2 1 11 Short Term Borrowings 12 6 7 5 2 1 2 0 Short Term Provisions 2 1 1 1 0 0 0 0 Total Liabilities 81 68 47 35 26 25 21 18 Net Block 21 21 9 9 9 9 11 12 Gross Block 32 32 18 17 16 15 14 14 Accumulated Depreciation 12 11 9 8 7 6 3 2 Non Current Assets 21 21 9 9 9 9 11 12 Capital Work in Progress 0 0 0 0 0 0 0 0 Non Current Investment 0 0 0 0 0 0 0 0 Long Term Loans & Adv. 0 0 0 0 0 0 0 0 Other Non Current Assets 0 0 0 0 0 0 0 0 Current Assets 60 47 38 26 17 16 10 6 Current Investments 0 0 0 0 0 0 0 0 Inventories 7 8 6 5 6 6 4 3 Sundry Debtors 42 32 26 16 6 8 4 2 Cash & Bank 4 1 1 1 0 1 1 0 Other Current Assets 7 2 0 0 4 2 1 1 Short Term Loans & Adv. 5 3 5 4 4 2 0 1 Net Current Assets 18 11 4 3 2 3 1 -7 Total Assets 81 68 47 35 26 25 21 18

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Shareholder's Funds

Share Capital

Total Reserves

-1

Non-Current Liabilities

Secured Loans

Unsecured Loans

Long Term Provisions

Current Liabilities

Trade Payables

Other Current Liabilities

Short Term Borrowings

Short Term Provisions

Total Liabilities

Net Block

Gross Block

Accumulated Depreciation

Non Current Assets

Capital Work in Progress

Non Current Investment

Long Term Loans & Adv.

Other Non Current Assets

Current Assets

Current Investments

Inventories

Sundry Debtors

Cash & Bank

Other Current Assets

Short Term Loans & Adv.

Net Current Assets

-7

Total Assets

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Cash From Operating Activity 7 1 5 2 3 4 -8 8 PBT 6 4 3 2 1 0 0 -2 Adjustment 6 4 4 3 3 5 2 2 Changes in Working Capital -2 -6 -1 -3 0 -1 -10 7 Cash after chg. in Working capital 10 2 5 2 3 4 -8 8 Interest Paid 0 0 0 0 0 0 0 0 Tax Paid -2 -1 -1 0 0 0 0 0 Other Direct Exp. Paid 0 0 0 0 0 0 0 0 Extra & Other Items 0 0 0 0 0 0 0 0 Cash From Investing Activity -1 -13 -1 -3 -2 -2 -2 -2 Net Fixed Assets -1 -13 -1 -1 -1 -1 0 Net Investments 0 0 0 0 0 0 0 Others 0 0 0 -2 -2 -1 -2 Cash from Financing Activity -4 13 -3 2 -1 -1 10 -5 Net Cash Inflow / Outflow 3 1 0 1 0 0 0 0 Opening Cash & Equivalents 1 1 1 0 1 1 0 0 Closing Cash & Equivalent 4 1 1 1 0 1 1 0

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Cash From Operating Activity

-8

PBT

-2

Adjustment

Changes in Working Capital

-2

-6

-1

-3

-1

-10

Cash after chg. in Working capital

-8

Interest Paid

Tax Paid

-2

-1

Other Direct Exp. Paid

Extra & Other Items

Cash From Investing Activity

-1

-13

-1

-3

-2

Net Fixed Assets

-1

-13

-1

Net Investments

Others

-2

-1

-2

Cash from Financing Activity

-4

-3

-1

-5

Net Cash Inflow / Outflow

Opening Cash & Equivalents

Closing Cash & Equivalent

Financial Ratios

Standalone

Description Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12
Book Value (Rs.) 56 45 20 13 8 7 6 6 ROA 8% 6% 7% 5% 2% 1% 0% -10% ROE 22% 24% 46% 42% 14% 8% -3% -73% ROCE 23% 22% 30% 23% 15% 13% 13% -3% Fixed Asset Turnover 3.80 3.05 3.81 3.32 2.37 2.33 1.13 0.48 Receivable days 111 138 113 75 68 62 74 125 Inventory Days 21 33 30 38 60 53 79 152 Payable days 76 120 115 99 108 87 110 134 Cash Conversion Cycle 56 51 28 14 20 29 43 143 Total Debt/Equity 0.82 0.80 1.83 2.84 3.78 4.50 5.87 5.29 Interest Cover 4 3 3 2 1 1 1 0

Description

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Book Value (Rs.)

ROA

-10%

ROE

22%

24%

46%

42%

14%

-3%

-73%

ROCE

23%

22%

30%

23%

15%

13%

-3%

Fixed Asset Turnover

3.80

3.05

3.81

3.32

2.37

2.33

1.13

0.48

Receivable days

111

138

113

125

Inventory Days

152

Payable days

120

115

108

110

134

Cash Conversion Cycle

143

Total Debt/Equity

0.82

0.80

1.83

2.84

3.78

4.50

5.87

5.29

Interest Cover

ANG Lifesciences India Ltd.

Pharmaceuticals & Drugs

BSE: 540694 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

ANG Lifesciences India Ltd.

Pharmaceuticals & Drugs

BSE: 540694 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update